Persistent formation of angiotensin II despite treatment with maximally recommended doses of angiotensin converting enzyme inhibitors in patients with chronic heart failure
2000 ◽
Vol 1
(2)
◽
pp. 147-150
◽
2000 ◽
Vol 36
(2)
◽
pp. 523-528
◽
2002 ◽
Vol 4
◽
pp. D111-D116
◽
1988 ◽
pp. 485-493
◽
2001 ◽
Vol 161
(2)
◽
pp. 165
◽
2005 ◽
Vol 61
(3)
◽
pp. 209-214
◽
2013 ◽
Vol 49
(3)
◽
pp. 330-340
◽
1996 ◽
Vol 2
(3)
◽
pp. 185-192
◽
2010 ◽
Vol 2
(1)
◽
pp. 33